Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe version history now shows Revision: v3.6.4 as the latest entry, replacing v3.6.3; this indicates an interface or metadata update rather than changes to trial content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new history entry for version 82 was added on 2026-07-07, with an accompanying Study Status update around 2026-07-09, and an older entry dated 2026-05-07 was deleted.SummaryDifference0.2%

- Check36 days agoChange DetectedThe record history now displays the latest platform revision as v3.6.3, replacing the previous v3.6.2 entry. This indicates a minor system release in the history view rather than a modification to the study information.SummaryDifference0.0%

- Check43 days agoChange DetectedA new site revision tag v3.6.2 was added, replacing v3.6.0, indicating a minor platform update reflected in the page's revision history.SummaryDifference0.0%

- Check57 days agoChange DetectedA new note states that recruitment is no longer ongoing, and the revision history has been updated to v3.6.0 with v3.5.5 removed, reflecting an administrative update to the record's versioning.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page shows a new revision label (v3.5.5) indicating an administrative update to the record history.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.